W. Gulliver

发表

Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab

W. Gulliver, Afsaneh Alavi, M. Wiseman, 2022, Journal of cutaneous medicine and surgery.

Regulation of parathyroid hormone-like peptide in cultured normal human keratinocytes. Effect of growth factors and 1,25 dihydroxyvitamin D3 on gene expression and secretion.

D. Banville, G. Hendy, W. Gulliver, 1991, The Journal of clinical investigation.

Understanding and Assessing Potential Serious Adverse Events: A Practical Approach to Understanding the Benefits and Harm of Psoriasis Treatments

W. Gulliver, K. Papp, Jerry Tan, 2013, Journal of cutaneous medicine and surgery.

Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population.

W. Gulliver, M. Mathews, Yagang Xie, 2005, The American journal of clinical nutrition.

Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta‐analysis of observational studies

P. Wolkenstein, C. Zouboulis, W. Gulliver, 2015, The British journal of dermatology.

Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document

W. Gulliver, M. Gooderham, S. Kalia, 2017, Journal of cutaneous medicine and surgery.

Long‐term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis

W. Gulliver, M. Lahfa, C. Paul, 2004, The Journal of dermatological treatment.

Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug.

J. Ortonne, W. Gulliver, K. Papp, 2002, The Journal of allergy and clinical immunology.

High dietary selenium intake is associated with less insulin resistance in the Newfoundland population

W. Gulliver, Guang Sun, Hongwei Zhang, 2017, PloS one.

Effects of 1 , 25 Dihydroxyvitatnin D 3 and Calciutn on Growth and Differentiation and on c-fos and p 53 Gene Expression in Nortnal Hutnan Keratinocytes

W. Gulliver, R. Kremer, M. Sebag, 2010 .

Effects of 1,25 Dihydroxyvitamin D3 and Calcium on Growth and Differentiation and on c-fos and p53 Gene Expression in Normal Human Keratinocytes

W. Gulliver, R. Kremer, M. Sebag, 1994 .

International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis.

Vinod K. Sharma, M. Lebwohl, A. Oakley, 2022, JAMA dermatology.

Update on Alefacept Safety

W. Gulliver, K. Papp, R. Bissonnette, 2009, Journal of cutaneous medicine and surgery.

Incorporating Biologics into the Treatment of Psoriasis

H. Lui, W. Gulliver, Y. Poulin, 2004, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of cutaneous medicine and surgery.

Incorporating Biologics into the Treatment of Psoriasis

H. Lui, W. Gulliver, Y. Poulin, 2004, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of Cutaneous Medicine and Surgery.

The Association of Serum Total Peptide YY (PYY) with Obesity and Body Fat Measures in the CODING Study

W. Gulliver, E. Randell, S. Vasdev, 2014, PloS one.

Short-Term Overfeeding Increases Circulating Adiponectin Independent of Obesity Status

W. Gulliver, E. Randell, S. Vasdev, 2013, PloS one.

What causes hidradenitis suppurativa ?—15 years after

A. Kimball, A. Martorell, G. Fabbrocini, 2020, Experimental dermatology.

The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials

W. Gulliver, C. Lynde, P. Fleming, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Serum Acylated Ghrelin Is Negatively Correlated with the Insulin Resistance In the CODING study

W. Gulliver, E. Randell, Weizhen Zhang, 2012, PloS one.

Long‐term prognosis in patients with psoriasis

W. Gulliver, 2008, The British journal of dermatology.

The Association Between an Addictive Tendency Toward Food and Metabolic Characteristics in the General Newfoundland Population

G. Zhai, W. Gulliver, W. Teng, 2018, Front. Endocrinol..

Weight Loss and Dietary Interventions for Hidradenitis Suppurativa: A Systematic Review

W. Gulliver, R. Alhusayen, P. Fleming, 2019, Journal of cutaneous medicine and surgery.

Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review

W. Gulliver, J. Pope, B. Haraoui, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies

W. Gulliver, C. Lynde, P. Fleming, 2016, The British journal of dermatology.

Psoriasis and Smoking

W. Gulliver, J. Pope, B. Haraoui, 2016, Journal of cutaneous medicine and surgery.

The Relationship of Obesity With the Severity of Psoriasis

W. Gulliver, C. Lynde, J. Kraft, 2015, Journal of cutaneous medicine and surgery.

Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa

C. Zouboulis, W. Gulliver, G. Jemec, 2016, Reviews in Endocrine and Metabolic Disorders.

Review of international psoriasis guidelines for the treatment of psoriasis: recommendations for topical corticosteroid treatments

J. M. van der Walt, L. Iversen, W. Gulliver, 2019, The Journal of dermatological treatment.

Dr. Roubille, et al reply

W. Gulliver, J. Pope, B. Haraoui, 2016, The Journal of Rheumatology.

Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease

W. Gulliver, K. Papp, N. Shear, 2008, Journal of cutaneous medicine and surgery.

The Incidence of Cutaneous Malignant Melanoma in Eastern Newfoundland and Labrador, Canada, from 2007 to 2015

W. Gulliver, S. Gulliver, Rebecca J Power, 2021, Dermatology.

Moisturizers and Ceramide-containing Moisturizers May Offer Concomitant Therapy with Benefits.

W. Gulliver, C. Lynde, S. Skotnicki, 2014, The Journal of clinical and aesthetic dermatology.

Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept

W. Gulliver, K. Papp, Y. Poulin, 2015, Journal of cutaneous medicine and surgery.

Transformation of 2,5-diphenyloxazole and derivatives by mixed-function oxidases of a marine fish

D. G. Walton, W. Penrose, W. Gulliver, 1979 .

Psoriasis Patients Treated With Biologics and Methotrexate Have a Reduced Rate of Myocardial Infarction

W. Gulliver, H. Bachelez, N. Al‐Mutairi, 2016, Journal of cutaneous medicine and surgery.

An Investigation of Comorbid Disease and Health Service Utilization Among Patients With Moderate to Severe Psoriasis in Newfoundland and Labrador

D. MacDonald, W. Gulliver, O. Chambenoit, 2018, Journal of cutaneous medicine and surgery.

Moderate-to-severe plaque psoriasis patients treated with ixekizumab: early real-world outcomes and adverse events

R. Burge, W. Gulliver, S. Gulliver, 2020, The Journal of dermatological treatment.

A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis.

W. Gulliver, K. Papp, G. Krueger, 2002, Journal of the American Academy of Dermatology.

Comparison of Management Guidelines for Moderate-to-Severe Plaque Psoriasis: A Review of Phototherapy, Systemic Therapies, and Biologic Agents

W. Gulliver, N. Shear, C. Lynde, 2018, Journal of cutaneous medicine and surgery.

Psoriasis Comorbidities

W. Gulliver, L. Guenther, 2009, Journal of cutaneous medicine and surgery.

Think beyond the Skin

W. Gulliver, Y. Poulin, C. Lynde, 2015, Journal of cutaneous medicine and surgery.

Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort

S. Connors, D. MacDonald, W. Gulliver, 2016, Journal of cutaneous medicine and surgery.

Meta‐Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials

W. Gulliver, J. Pope, B. Haraoui, 2015, Arthritis care & research.

An analysis of the incidence of adverse pregnancy outcomes among women with psoriasis in Newfoundland and Labrador

D. MacDonald, W. Gulliver, A. Morrissey, 2015 .

Long-Term Prognosis and Comorbidities Associated with Psoriasis in the Newfoundland and Labrador Founder Population

P. Rahman, R. Alaghehbandan, D. MacDonald, 2011, Journal of cutaneous medicine and surgery.

Cyclosporine in the treatment of psoriasis.

W. Gulliver, 2000, Cutis.

Human papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix.

W. Gulliver, M. M. Pater, A. Pater, 1992, The American journal of pathology.

Insights and advances in chronic urticaria: a Canadian perspective

William H. Yang, F. Simons, P. Vadas, 2015, Allergy, Asthma & Clinical Immunology.

Best practices for the prevention and treatment of venous leg ulcers.

W. Gulliver, P. Houghton, R. Sibbald, 2001, Ostomy/wound management.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody.

H. Lui, J. Shapiro, W. Gulliver, 2001, Journal of the American Academy of Dermatology.

HLA-Cw6 status predicts efficacy of biologic treatments in psoriasis patients

W. Gulliver, S. Gulliver, H. M. Young, 2016 .

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

A. Kimball, A. Martorell, C. Zouboulis, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Endpoints of clinical trials for Hidradenitis Suppurativa: Proceedings of a round‐table session

C. Zouboulis, W. Gulliver, G. Jemec, 2020, Experimental dermatology.

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

W. Gulliver, S. Forman, A. Armstrong, 2019, The British journal of dermatology.

Checklist for the Systemic Treatment of Psoriasis Using Biologics: A Delphi Study

W. Gulliver, M. Gooderham, C. Fahim, 2019, Journal of cutaneous medicine and surgery.

An Open Letter to Health Canada

W. Gulliver, M. Wiseman, M. Gooderham, 2017, Journal of cutaneous medicine and surgery.

In vitro interaction of 7,12-dimethylbenz[a]anthracene and its biliary metabolites with dietary fiber.

W. Gulliver, J. Barrowman, J. Laher, 1983, Journal of the National Cancer Institute.

A review of biologic treatments for psoriasis with emphasis on infliximab.

W. Gulliver, S. Pirzada, Z. Tomi, 2007, Skin therapy letter.

Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study

W. Gulliver, M. Wiseman, M. Gooderham, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Development and Validation of a Comprehensive Acne Severity Scale

W. Gulliver, Y. Poulin, Jerry Tan, 2007, Journal of cutaneous medicine and surgery.

Support Needed to Involve Psoriasis Patients in Treatment Decisions: Survey of Dermatologists

H. Lui, W. Gulliver, D. Stacey, 2011, Journal of cutaneous medicine and surgery.

The Relationship Between Dermatologist- and Patient-Reported Acne Severity Measures and Treatment Recommendations

W. Gulliver, M. Frey, Y. Poulin, 2015, Journal of cutaneous medicine and surgery.

Development and Validation of a Scale for Acne Scar Severity (SCAR-S) of the Face and Trunk

W. Gulliver, Y. Poulin, Jerry Tan, 2010, Journal of cutaneous medicine and surgery.

QUICK REFERENCE GUIDE TO THE 12 RECOMMENDATIONS FOR BEST PRACTICES IN THE PREVENTION AND TREATMENT OF VENOUS LEG ULCERS

W. Gulliver, P. Houghton, R. Sibbald, 2022 .

Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting

W. Gulliver, O. Chambenoit, S. Gulliver, 2018, Journal of cutaneous medicine and surgery.

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.

J. Ortonne, F. G. Larsen, W. Gulliver, 2002, Acta dermato-venereologica.

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.

J. Leyden, W. Gulliver, N. Shear, 1997, Journal of the American Academy of Dermatology.

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis

W. Gulliver, J. Pope, B. Haraoui, 2015, Annals of the rheumatic diseases.

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

A. Kimball, W. Gulliver, J. Kirby, 2021, Journal of the American Academy of Dermatology.

Secukinumab-Induced Psoriasiform Eruption.

W. Gulliver, C. Sladden, M. Sladden, 2017, JAMA dermatology.

Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials

W. Gulliver, S. Walsh, C. Rosen, 2018, The British journal of dermatology.

Search for the psoriasis susceptibility gene: the Newfoundland Study.

W. Gulliver, E. Farber, P. Charmley, 1999, Cutis.

Canadian Hand Dermatitis Management Guidelines

T. Agner, W. Gulliver, R. Bissonnette, 2010, Journal of cutaneous medicine and surgery.

Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.

W. Gulliver, H. H. van der Zee, 2016, Dermatologic clinics.

Toenail Onychomycosis—A Canadian Approach With a New Transungual Treatment

W. Gulliver, D. Keast, R. Sibbald, 2015, Journal of cutaneous medicine and surgery.

Case Report: Orofacial Granulomatosis

W. Gulliver, R. Fowler, M. Pratt, 2015 .

Treatment of Mild to Moderate Psoriasis with Reliéva, a Mahonia aquifolium Extract—A Double-Blind, Placebo-Controlled Study

W. Gulliver, R. Norman, H. Donsky, 2006, American journal of therapeutics.

A Report on Three Recent Clinical Trials Using Mahonia aquifolium 10% Topical Cream and a Review of the Worldwide Clinical Experience With Mahonia aquifolium for the Treatment of Plaque Psoriasis

W. Gulliver, H. Donsky, 2005, American journal of therapeutics.

Cyclosporine in the management of esophageal lichen planus.

W. Gulliver, M. Chaklader, J. McGrath, 2009, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

Ornithine Decarboxylase Activity and Polyamine Content during Zoospore Germination and Hormone-induced Sexual Differentiation of Achlya ambisexualis

W. Gulliver, S. Boyle, J. Wright, 1982 .

Hidradenitis Suppurativa: A Novel Model of Care and an Integrative Strategy to Adopt an Orphan Disease

W. Gulliver, D. Morgan, I. Landells, 2018, Journal of cutaneous medicine and surgery.

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)*

A. Menter, W. Gulliver, C. Leonardi, 2014, The British journal of dermatology.

Divergence of Demographic Factors Associated with Clinical Severity Compared with Quality of Life Impact in Acne

W. Gulliver, Y. Poulin, Jerry Tan, 2008, Journal of cutaneous medicine and surgery.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

Mehrad Amin Eskandari, J. F. Tinto, A. Capucci, 2018, Indian heart journal.

Treating to Target(s) With Interleukin-17 Inhibitors

P. Rahman, W. Gulliver, K. Papp, 2019, Journal of cutaneous medicine and surgery.

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

A. Ogdie, P. Rahman, A. Neimann, 2022, BMJ Open.

High Dietary Magnesium Intake Is Associated with Low Insulin Resistance in the Newfoundland Population

W. Gulliver, E. Randell, S. Vasdev, 2013, PloS one.

Treatment Persistence of Ixekizumab in Adults with Moderate-to-Severe Plaque Psoriasis Participating in the Canadian Patient Support Program

R. Burge, W. Gulliver, M. Gooderham, 2022, Dermatology and Therapy.

Review of Systemic Treatment Options for Adult Atopic Dermatitis

W. Gulliver, M. Gooderham, K. Papp, 2017, Journal of cutaneous medicine and surgery.

Importance of screening for comorbidities in psoriasis patients

W. Gulliver, 2008 .

Higher Dietary Choline and Betaine Intakes Are Associated with Better Body Composition in the Adult Population of Newfoundland, Canada

W. Gulliver, E. Randell, Y. Yi, 2016, PloS one.

Food Addiction: Its Prevalence and Significant Association with Obesity in the General Population

G. Zhai, W. Gulliver, E. Randell, 2013, PloS one.

Clinical Medicine Insights: Endocrinology and Diabetes

W. Gulliver, E. Randell, S. Vasdev, 2010 .

Peptide T exhibits a well‐defined structure in fluorinated solvent at low temperature

J. Rendell, W. Gulliver, V. Booth, 2009, Journal of peptide science : an official publication of the European Peptide Society.

Serum metabolic biomarkers distinguish metabolically healthy peripherally obese from unhealthy centrally obese individuals

G. Zhai, W. Gulliver, E. Randell, 2016, Nutrition & Metabolism.

Two novel candidate genes identified in adults from the Newfoundland population with addictive tendencies towards food

G. Zhai, W. Gulliver, Hongwei Zhang, 2017, Appetite.

Neoral® in the Treatment of Psoriasis: Consensus Treatment Guidelines

W. Gulliver, K. Papp, D. Sauder, 1997 .

Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasis.

A. Menter, W. Gulliver, K. Gordon, 2005, Archives of dermatology.

Significant Beneficial Association of High Dietary Selenium Intake with Reduced Body Fat in the CODING Study

W. Gulliver, Hongwei Zhang, Y. Yi, 2016, Nutrients.

Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects.

W. Gulliver, Y. Yi, J. Shea, 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

ISA247: Quality of Life Results from a Phase II, Randomized, Placebo-Controlled Study

W. Gulliver, C. Lynde, R. Langley, 2008, Journal of cutaneous medicine and surgery.

The Use of Alefacept in the Treatment of Psoriasis

W. Gulliver, Y. Poulin, L. Guenther, 2004, Journal of cutaneous medicine and surgery.

Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.

C. Zouboulis, W. Gulliver, G. Nikolakis, 2021, JAMA dermatology.

Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative

W. Gulliver, J. Pope, B. Haraoui, 2015, The Journal of Rheumatology.

Psoriasis challenge: are we meeting the needs of our patients?

W. Gulliver, 2013 .

Beneficial association of serum ghrelin and peptide YY with bone mineral density in the Newfoundland population

W. Gulliver, Hongwei Zhang, G. Paterno, 2013, BMC Endocrine Disorders.

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice

D. Gladman, P. Rahman, J. Karsh, 2017, The Journal of Rheumatology.

Prevalence and severity of facial and truncal acne in a referral cohort.

W. Gulliver, Y. Poulin, Jerry Tan, 2008, Journal of drugs in dermatology : JDD.

Quality of Life in Patients with Immune-Mediated Inflammatory Diseases

S. Albani, W. Gulliver, A. Russell, 2011, The Journal of Rheumatology. Supplement.

Omalizumab Retreatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial.

William H. Yang, W. Gulliver, M. Gooderham, 2020, The journal of allergy and clinical immunology. In practice.

Concordance of BAI and BMI with DXA in the Newfoundland Population

W. Gulliver, T. Bridger, Yagang Xie, 2013, Obesity.

Effective Treatment of Chronic Hand Dermatitis with 36 Continuous Months of Alitretinoin Administration: Report of Three Cases

W. Gulliver, K. A. Baker, 2012, Journal of Cutaneous Medicine and Surgery.

Weight change in patients with psoriasis using tumour necrosis factor‐α inhibitors

W. Gulliver, P. Fleming, A. Muntyanu, 2019, The British journal of dermatology.

Cumulative life course impairment in psoriasis: patient perception of disease‐related impairment throughout the life course

W. Gulliver, R. Warren, C. E. Kleyn, 2011, The British journal of dermatology.

Treatment Decision Needs of Psoriasis Patients: Cross-sectional Survey

H. Lui, W. Gulliver, D. Stacey, 2010, Journal of cutaneous medicine and surgery.

2016 Addendum to the Canadian Guidelines for the Management of Plaque Psoriasis 2009

W. Gulliver, M. Wiseman, M. Gooderham, 2016 .

Effect of Quality of Life Impact and Clinical Severity on Adherence to Topical Acne Treatment

W. Gulliver, Y. Poulin, Jerry Tan, 2009, Journal of cutaneous medicine and surgery.

Investigating the therapeutic potential of a probiotic in a clinical population with chronic hand dermatitis

W. Gulliver, N. Ship, Andrew S Hutton, 2018, Clinical, cosmetic and investigational dermatology.

Development and validation of IHS4‐55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa

A. Kyrgidis, W. Gulliver, K. R. van Straalen, 2022, Journal of the European Academy of Dermatology and Venereology.

External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort

A. Kyrgidis, A. Molina-Leyva, C. Zouboulis, 2023, Dermatology.

Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa

W. Gulliver, G. Jemec, K. Baker, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

Adverse Reactions to Biologics

W. Gulliver, L. Puig, 2017 .

A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence

W. Gulliver, K. Papp, Y. Poulin, 2005, Journal of cutaneous medicine and surgery.

Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin *

W. Gulliver, G. F. Murphy, D. Primmett, 1996, The British journal of dermatology.

Arsenic Keratosis in a Patient from Newfoundland and Labrador, Canada

W. Gulliver, M. Pratt, Patricia Wadden, 2016, Journal of cutaneous medicine and surgery.

Depression Over Psoriasis: Assessment of associated Relief by addition of ADalimumab for the treatment of Psoriasis: Observational study (DORADO - Ps)

W. Gulliver, Ayman Elgendi, H. Nada, 2015 .

Development of Psoriasis Assessment Tools Among Patients in the CorEvitas Psoriasis Registry

R. Burge, W. Gulliver, C. Leonardi, 2023, Journal of Psoriasis and Psoriatic Arthritis.

A partitioned 88-loci psoriasis genetic risk score reveals HLA and non-HLA contributions to clinical phenotypes in a Newfoundland psoriasis cohort

W. Liao, L. Tsoi, W. Gulliver, 2023, Frontiers in Genetics.

Investigation of prevalence of biologic use and discontinuation rates in moderate‐to‐severe psoriasis patients in Newfoundland and Labrador using real‐world data

W. Gulliver, S. Gulliver, 2021, Dermatologic therapy.

Assessing Skin Cancer Risk Factors, Sun Safety Behaviors and Melanoma Concern in Atlantic Canada: A Comprehensive Survey Study

E. Rahme, W. Gulliver, S. Peláez, 2023, Cancers.

The role of Apligraf in the treatment of venous leg ulcers.

W. Gulliver, L. Guenther, R. Sibbald, 1999, Ostomy/wound management.

W. Gulliver, B. Haraoui, C. Roubille, 2015, The Journal of Rheumatology.

THU0412 Cardiovascular Outcomes in Patients with Rheumatoid Arthritis, Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analyses

W. Gulliver, J. Pope, B. Haraoui, 2014 .

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

W. Gulliver, M. Gooderham, K. Papp, 2023, Journal of cutaneous medicine and surgery.

The AWARE Study: Methodology and Baseline Characteristics

H. Lui, W. Gulliver, K. Papp, 2009, Journal of Cutaneous Medicine and Surgery.

Real World Studies of Psoriasis and Mental Illness in Newfoundland and Labrador

P. Rahman, W. Gulliver, K. Lester, 2022, Journal of cutaneous medicine and surgery.

The expected missing heritability of hidradenitis suppurativa in perspective

W. Gulliver, K. R. van Straalen, 2021, The British journal of dermatology.

Arsenic Keratosis in a Patient from Newfoundland and Labrador, Canada

W. Gulliver, M. Pratt, Patricia Wadden, 2016, Journal of cutaneous medicine and surgery.

Two novel candidate genes identified in adults from the Newfoundland population with addictive tendencies towards food

G. Zhai, W. Gulliver, Hongwei Zhang, 2017, Appetite.

Canadian Guidelines for the Management of Plaque Psoriasis: Overview

J. Ashkenas, W. Gulliver, K. Papp, 2011, Journal of cutaneous medicine and surgery.

A randomized controlled study of combination therapy with alefacept and narrow band UVB phototherapy (UVB) for moderate to severe psoriasis: efficacy, onset, and duration of response.

H. Lui, W. Gulliver, N. Shear, 2012, Journal of Drugs in Dermatology.